Skip to content
DraconiticResearch
Search Sources API
194,164 studies31 sourcesUpdated 19 min ago
Peer-reviewedLicence not statedPsychopharmacology Bulletin

Psychiatric and Behavioral Adverse Event Reporting Patterns Among Dopamine Agonists in Parkinson’s Disease Using the Food and Drug Administration Adverse Event Reporting System

  • Toru Ogura
  • Chihiro Shiraishi
Read full textDOICite

Related

  1. Signal of venous thromboembolism with ethinyl estradiol vs natural estrogens in oral contraceptives: analysis of the EudraVigilance and Food and Drug Administration Adverse Events Reporting System databases
    Lucie Raskin, Marie Didembourg, Médéa Locquet +4
    Research and Practice in Thrombosis and HaemostasisPeer-reviewedCC BYFull textPharmacology & toxicologyDOAJEurope PMCPMC
  2. A non-destructive methodological framework for modernizing legacy clinical reporting systems for AI-driven pharmacoinformatics: a SAS case study
    Jaime Yan
    Frontiers in pharmacologyPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
  3. Corticosteroid dose reporting in atraumatic osteonecrosis of the humeral head: a scoping review
    Thomas Ciavarro, Amr Elmaraghy, Patrick J. Carroll
    JSES reviews, reports, and techniquesPeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMC
  4. Safety of stroboscopic visual training in athletes: a mini-review and proposed framework for adverse-event reporting
    Jianjun Li, Youlin Xiao, Shiwei Xiao
    Frontiers in physiologyPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Effect Estimates, Effect Sizes, Confidence Intervals, and P-values: A Framework for Reporting and Interpreting Biomedical Research
    Himel Mondal, Sukrita Sukrita, Anjali Sinha +2
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{ogura2026psychiatric,
  title = {{Psychiatric and Behavioral Adverse Event Reporting Patterns Among Dopamine Agonists in Parkinson’s Disease Using the Food and Drug Administration Adverse Event Reporting System}},
  author = {Toru Ogura and Chihiro Shiraishi},
  journal = {Psychopharmacology Bulletin},
  year = {2026},
  month = oct,
  doi = {10.64719/pb.21621},
  url = {https://doi.org/10.64719/pb.21621},
}
RIS
TY  - JOUR
TI  - Psychiatric and Behavioral Adverse Event Reporting Patterns Among Dopamine Agonists in Parkinson’s Disease Using the Food and Drug Administration Adverse Event Reporting System
AU  - Toru Ogura
AU  - Chihiro Shiraishi
PY  - 2026
DA  - 2026/10/30
JO  - Psychopharmacology Bulletin
DO  - 10.64719/pb.21621
UR  - https://doi.org/10.64719/pb.21621
SN  - 0048-5764
SN  - 2472-2448
ER  -